← Eichor
Study identifier: NCT07516873 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Exploring the Effects of Brief Mindfulness Training With Vagal Nerve Stimulation on Alcohol Cue Reactivity Among Young Adult Heavy Drinkers

Condition: Heavy Drinking  ·  Sponsor: Cambridge Health Alliance

PhaseNA
Planned participants50
Who can joinAll sexes, 21 Years to 29 Years
Healthy volunteersNo

About this study

The present study will assess the acceptability and feasibility of a brief intervention designed to help young heavy drinkers reduce their alcohol consumption. All participants will complete a brief (1-week) mindfulness intervention, and participants will be randomized to receive either active or inactive Respiratory-gated Auricular Vagal Afferent Nerve Stimulation (RAVANS) during two in-person laboratory visits. Heart rate variability data and self-report survey data will be collected to assess the impact of the intervention on autonomic regulation, alcohol consumption, and additional clinical measures.

This description comes directly from the study's public registry record.

Talk to the study team

Frannie Marin, BS  ·  (617)-643-8770  ·  fmarin@challiance.org

Michael Datko, PhD  ·  mdatko@challiance.org

Always discuss trial participation with your own doctor first.

Locations (1)

Center for Mindfulness and CompassionMalden, Massachusetts, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07516873